Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. Published

    Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

    Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

    Kjaer, L., Holmström, M. O., Cordua, S., Andersen, Mads Hald, Svane, Inge Marie, Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, Hans Carl, Apr 2018, In: Leukemia and Lymphoma. 59, 4, p. 973-977 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

    Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., dqp123, dqp123, Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, Helle Westergren, Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, Mads Hald & Svane, Inge Marie, 2021, In: Nature Medicine. 27, p. pages2212–2223

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Cancerimmunterapi

    Kjeldsen, J. W., dqp123, dqp123 & Svane, Inge Marie, 2018, In: Ugeskrift for Laeger. 180, 5 p., V09170691.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report

    Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 2018, In: Frontiers in Immunology. 9, SEP, 6 p., 2145.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

    Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

    Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

    Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A., Hentze, J., Andresen, B., Svane, I., Gerstoft, J., Kronborg, G., Fomsgaard, A., Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A. E., Hentze, J. L., Andresen, B. S. & 4 others, Svane, I. M., Gerstoft, J., Kronborg, Gitte & Fomsgaard, A., 2009, In: AIDS. 23, 11, p. 1329-40 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Immunterapi er kræftbehandling med en helt ny bivirkningsprofil

    Kondrup, M., Raunkilde, L., Svane, Inge Marie, Schmidt, H. & Bastholt, L., 2017, In: Ugeskrift for Laeger. 179, 5 p., V05170365.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H., Bisbjerg, R., Daugaard, G. & Sengeløv, L., Aug 2016, In: Anti-Cancer Drugs. 27, 7, p. 695-701 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., Apr 2017, In: Clinical Genitourinary Cancer. 15, 2, p. e281-e287

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

    Kongsted, P., Svane, Inge Marie, Lindberg, H., Daugaard, G. & Sengeløv, L., Nov 2015, In: Urologic Oncology: Seminars and Original Investigations. 33, 11, p. 494.e15-20

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer

    Kongsted, P., Svane, Inge Marie, Lindberg, H. & Sengeløv, L., 2016, In: Clinical Genitourinary Cancer. 14, 6, p. e559-e568

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

    Kongsted, P., Borch, T. H., Ellebaek, E., Iversen, T. Z., Andersen, R., Met, Özcan, Hansen, M., Lindberg, H., Sengeløv, L. & Svane, Inge Marie, 1 Apr 2017, In: Cytotherapy. 19, 4, p. 500-513 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

    Kristensen, N. P., Heeke, C., Tvingsholm, S. A., Borch, A., Draghi, A., Crowther, M. D., Carri, I., Munk, K. K., Holm, J. S., Bjerregaard, A. M., Bentzen, A. K., Marquard, A. M., Szallasi, Z., McGranahan, N., Andersen, R., Nielsen, M., Jönsson, G. B., dqp123, dqp123, Svane, Inge Marie & Hadrup, S. R., 2022, In: Journal of Clinical Investigation. 132, 2, p. 1-16 150535.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Collagen density regulates the activity of tumor-infiltrating T cells

    Kuczek, D. E., Larsen, A. M. H., Thorseth, M., Carretta, M., Kalvisa, A., Siersbæk, M. S., Simões, A. M. C., Roslind, A., Engelholm, Lars Henning, Noessner, E., dqp123, dqp123, Svane, Inge Marie, Straten, P. T., Grøntved, L. & Madsen, D. H., 2019, In: Journal for ImmunoTherapy of Cancer. 7, 1, 15 p., 68.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Supervised clustering of peripheral immune cells associated with clinical response to checkpoint inhibitor therapy in patients with advanced melanoma

    Kverneland, Anders Handrup, Thorsen, S. U., Granhøj, J. S., Hansen, F. S., Konge, M., Ellebæk, E., Donia, M. & Svane, Inge Marie, 2023, In: Immuno-Oncology and Technology. 20, 10 p., 100396.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published
  20. Published

    Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition

    Kverneland, Anders Handrup, Borch, T. H., Granhøj, J., Sengeløv, Henrik, Donia, M. & Svane, Inge Marie, Aug 2021, In: Cytotherapy. 23, 8, p. 724-729 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Kverneland, Anders Handrup, Pedersen, M., Wulff Westergaard, M. C., Nielsen, M., Borch, T. H., Olsen, L. R., Aasbjerg, G., Santegoets, S. J., van der Burg, S. H., Milne, K., Nelson, B. H., Met, Özcan, dqp123, dqp123 & Svane, Inge Marie, 2020, In: OncoTarget. 11, 22, p. 2092-2105 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab

    Kverneland, A. H., Enevold, C., dqp123, dqp123, Bastholt, L., Svane, Inge Marie & Nielsen, C. H., 2018, In: OncoImmunology. 7, 5, p. e1424674 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Characterization of a single peptide derived from cytochrome P4501B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients

    Kvistborg, P., Hadrup, S. R., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2008, In: Human Immunology. 69, 4-5, p. 266-272 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Functional characterization of Foxp3-specific spontaneous immune responses

    Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In: Leukemia. 27, 12, p. 2332-40 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Spontaneous presence of FOXO3-specific T cells in cancer patients

    Larsen, S. K., Ahmad, S. M., Idorn, M., Met, Özcan, Martinenaite, E., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 1 Jan 2014, In: OncoImmunology. 3, 8, e953411.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4054758